Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM StudyBella Kaufman, Alison Jones, John R. Mackey et al.|Journal of Clinical Oncology|2009Cited by 850
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016Preet K. Dhillon, Jagadish Mahanta, G Anil Kumar et al.|The Lancet Oncology|2018Cited by 488